Denali Therapeutics Inc.
DNLI
$14.12
-$0.20-1.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.70% | -19.54% | -24.58% | -24.76% | -27.29% |
| Total Receivables | -10.53% | -36.52% | -33.33% | -58.82% | -40.63% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 69.55% | 14.23% | -2.06% | 4.26% | 3.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -9.75% | -18.77% | -23.98% | -24.16% | -26.53% |
|
|
|||||
| Total Current Assets | -9.75% | -18.77% | -23.98% | -24.16% | -26.53% |
| Net Property, Plant & Equipment | 80.02% | 75.37% | 51.27% | 7.99% | 2.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -39.64% | -46.31% | 137.83% | 250.41% | 218.36% |
| Total Assets | -19.59% | 19.09% | 17.56% | 15.07% | 12.19% |
|
|
|||||
| Total Accounts Payable | -28.65% | 17.44% | 711.68% | 63.57% | 435.21% |
| Total Accrued Expenses | 13.37% | 5.99% | 0.97% | -7.89% | -39.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.28% | 65.76% | 15.30% | 14.72% | 14.88% |
| Total Finance Division Other Current Liabilities | 38.70% | -- | 57.13% | 30.83% | -95.81% |
| Total Other Current Liabilities | 38.70% | -- | 57.13% | 30.83% | -95.81% |
| Total Current Liabilities | 11.26% | 31.07% | 22.36% | 7.46% | -78.88% |
|
|
|||||
| Total Current Liabilities | 11.26% | 31.07% | 22.36% | 7.46% | -78.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.94% | -5.99% | -5.13% | -15.94% | -14.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 940.63% | -- | -- |
| Total Liabilities | 18.34% | 17.51% | 14.41% | -2.86% | -71.62% |
|
|
|||||
| Common Stock & APIC | 4.40% | 28.89% | 29.37% | 29.78% | 30.48% |
| Retained Earnings | -37.27% | -37.88% | -42.89% | -46.76% | -12.70% |
| Treasury Stock & Other | 257.18% | 214.15% | 949.31% | -84.52% | 48.51% |
| Total Common Equity | -22.86% | 19.28% | 17.90% | 16.87% | 50.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -22.86% | 19.28% | 17.90% | 16.87% | 50.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.86% | 19.28% | 17.90% | 16.87% | 50.56% |
|
|
|||||